Is FFKT or MRK a better dividend investment in 2026?

FFKT currently yields 3.51% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: FFKT offers higher current income.

What is the dividend yield difference between FFKT and MRK?

FFKT has a forward dividend yield of 3.51% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 0.26 percentage points.

Home › Compare › FFKT vs MRK

FFKT vs MRK: Dividend Comparison 2026

FFKT yields 3.51% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FFKT wins by $734.79M in total portfolio value

INVESTMENT

TIME HORIZON10 years

FFKT

● Live price

3.51%

Share price

$56.90

Annual div

$2.00

5Y div CAGR

98.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$734.82M

Annual income

$694,510,301.43

Full FFKT calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — FFKT vs MRK

📍 FFKT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FFKT	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FFKT + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FFKT pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FFKT

Annual income on $10K today (after 15% tax)

$298.77/yr

After 10yr DRIP, annual income (after tax)

$590,333,756.22/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, FFKT beats the other by $590,332,948.47/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FFKT + MRK for your $10,000?

FFKT: 50%MRK: 50%

100% MRK50/50100% FFKT

Portfolio after 10yr

$367.43M

Annual income

$347,255,625.87/yr

Blended yield

94.51%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FFKT

Analyst Ratings

Hold

Consensus: Hold

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FFKT buys

MRK buys

No recent congressional trades found for FFKT or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFFKTMRK

Forward yield	3.51% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	98.8% ✓	8.2%
Portfolio after 10y	$734.82M ✓	$30.7K
Annual income after 10y	$694,510,301.43 ✓	$950.29
Total dividends collected	$731.88M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: FFKT vs MRK ($10,000, DRIP)

Year	FFKT Portfolio	FFKT Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$11,399	$698.77	$11,192	$351.54	+$207.00 → FFKT
2	$13,677	$1,479.87	$12,524	$392.70	+$1.2K → FFKT
3	$17,933	$3,298.95	$14,015	$438.65	+$3.9K → FFKT
4	$27,225	$8,036.77	$15,682	$489.96	+$11.5K → FFKT
5	$51,800	$22,668.96	$17,547	$547.23	+$34.3K → FFKT
6	$135,561	$80,135.31	$19,632	$611.16	+$115.9K → FFKT
7	$534,691	$389,640.64	$21,963	$682.53	+$512.7K → FFKT
8	$3,427,507	$2,855,387.55	$24,571	$762.18	+$3.40M → FFKT
9	$37,674,818	$34,007,385.63	$27,486	$851.08	+$37.65M → FFKT
10	$734,822,357	$694,510,301.43	$30,745	$950.29	+$734.79M → FFKT

FFKT vs MRK: Complete Analysis 2026

FFKT — Stock

FFKT is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in FFKT shares.

Full FFKT Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this FFKT vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FFKT vs SCHD FFKT vs JEPI FFKT vs O FFKT vs KO FFKT vs MAIN FFKT vs JNJ FFKT vs ABBV FFKT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.